Frontiers in liver transplantation
- PMID: 32463145
- DOI: 10.1002/bjs.11714
Frontiers in liver transplantation
References
-
- Khan AS, Adams N, Vachharajani N, Dageforde L, Wellen J, Shenoy S et al. Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: a retrospective cohort study. Int J Surg 2020; 75: 84-90.
-
- Flemming JA, Kim WR, Brosgart CL, Terrault NA. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 2016; 65: 804-812.
-
- Molnar MZ, Nair S, Cseprekal O, Yazawa M, Talwar M, Balaraman V et al. Transplantation of kidneys from hepatitis C infected donors to hepatitis C negative recipients: single center experience. Am J Transplant 2019; 19: 3046-3057.
-
- Holmer M, Melum E, Isoniemi H, Ericzon BG, Castedal M, Nordin A et al. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. Liver Int 2018; 38: 2082-2090.
-
- O'Neill S, Srinivasa S, Callaghan CJ, Watson CJ, Dark JH, Fisher AJ et al. Novel organ perfusion and preservation strategies in transplantation - where are we going in the UK? Transplantation 2020: 1. https://doi.org/10.1097/TP.0000000000003106 [Epub ahead of print].
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
